|
US20050065161A1
(en)
*
|
1996-02-02 |
2005-03-24 |
Nitromed, Inc. |
Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
|
|
US6416778B1
(en)
*
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
|
US6630168B1
(en)
*
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
|
US6416779B1
(en)
*
|
1997-06-11 |
2002-07-09 |
Umd, Inc. |
Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
|
|
US6472425B1
(en)
|
1997-10-31 |
2002-10-29 |
Nitromed, Inc. |
Methods for treating female sexual dysfunctions
|
|
US6958148B1
(en)
|
1998-01-20 |
2005-10-25 |
Pericor Science, Inc. |
Linkage of agents to body tissue using microparticles and transglutaminase
|
|
US6919076B1
(en)
|
1998-01-20 |
2005-07-19 |
Pericor Science, Inc. |
Conjugates of agents and transglutaminase substrate linking molecules
|
|
WO1999060938A1
(en)
|
1998-05-23 |
1999-12-02 |
Focal, Inc. |
Method of treatment for premature rupture of membranes in pregnancy (prom)
|
|
IL127129A
(en)
*
|
1998-11-18 |
2004-06-01 |
Ferring Bv |
Method for preparation of progesterone tablets for vaginal delivery and tablets so prepared
|
|
US20070178139A1
(en)
*
|
1998-11-18 |
2007-08-02 |
Yankov Vladimir I |
Vaginally administratable progesterone-containing tablets and method for preparing same
|
|
US6350464B1
(en)
|
1999-01-11 |
2002-02-26 |
Guilford Pharmaceuticals, Inc. |
Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
|
|
US6537566B1
(en)
|
1999-03-11 |
2003-03-25 |
John Alton Copland |
Compositions and methods for the non-invasive treatment of uterine fibroid cells
|
|
US6537585B1
(en)
|
1999-03-26 |
2003-03-25 |
Guilford Pharmaceuticals, Inc. |
Methods and compositions for treating solid tumors
|
|
US6375970B1
(en)
*
|
1999-07-07 |
2002-04-23 |
Andre Bieniarz |
Methods and materials for preterm birth prevention
|
|
WO2001085013A2
(en)
*
|
2000-05-09 |
2001-11-15 |
Nitromed, Inc. |
Infrared thermography and methods of use
|
|
US20050042194A1
(en)
*
|
2000-05-11 |
2005-02-24 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
US6613355B2
(en)
|
2000-05-11 |
2003-09-02 |
A.P. Pharma, Inc. |
Semi-solid delivery vehicle and pharmaceutical compositions
|
|
EP1315777B1
(en)
|
2000-09-06 |
2007-10-31 |
AP Pharma, Inc. |
Degradable polyacetal polymers
|
|
WO2002028660A2
(en)
|
2000-10-02 |
2002-04-11 |
Kimberly-Clark Worldwide, Inc. |
Nanoparticle based inks and methods of making the same
|
|
US6590059B2
(en)
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
|
US20030134892A1
(en)
*
|
2001-07-19 |
2003-07-17 |
Wenbin Dang |
Compositions for treatment of head and neck cancers, and methods of making and using the same
|
|
WO2003007914A2
(en)
*
|
2001-07-19 |
2003-01-30 |
Guilford Pharmaceuticals, Inc. |
Biocompatible polymer containing composition for treatment of prostate cancers
|
|
US8425892B2
(en)
*
|
2001-10-29 |
2013-04-23 |
Columbia Laboratories, Inc. |
Extended, controlled-release pharmaceutical compositions using charged polymers
|
|
US20030114394A1
(en)
*
|
2001-10-29 |
2003-06-19 |
Levine Howard L. |
Vaginally administered anti-dysrhythmic agents for treating pelvic pain
|
|
US20080182841A1
(en)
*
|
2001-10-29 |
2008-07-31 |
Levine Howard L |
Vaginally administered anti-dysrhythmic agents for treating pelvic pain
|
|
US6524606B1
(en)
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
|
JP2005513080A
(ja)
*
|
2001-12-20 |
2005-05-12 |
フェムファーマ， インコーポレイテッド |
薬物の膣送達
|
|
US20060177495A1
(en)
*
|
2001-12-21 |
2006-08-10 |
Christine Allen |
Polymer-lipid delivery vehicles
|
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
|
EP1543841A4
(en)
*
|
2002-08-15 |
2011-03-16 |
Yunqing Liu |
SOLID PHARMACEUTICAL NANO FORMULATION AND MANUFACTURING METHOD THEREFOR
|
|
US7045589B2
(en)
*
|
2002-11-15 |
2006-05-16 |
A.P. Pharma, Inc. |
Bioerodible poly(ortho esters) from dioxane-based di(ketene acetals), and block copolymers containing them
|
|
US8409618B2
(en)
|
2002-12-20 |
2013-04-02 |
Kimberly-Clark Worldwide, Inc. |
Odor-reducing quinone compounds
|
|
US7666410B2
(en)
|
2002-12-20 |
2010-02-23 |
Kimberly-Clark Worldwide, Inc. |
Delivery system for functional compounds
|
|
US6780896B2
(en)
|
2002-12-20 |
2004-08-24 |
Kimberly-Clark Worldwide, Inc. |
Stabilized photoinitiators and applications thereof
|
|
US9173836B2
(en)
*
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
|
MXPA05007266A
(es)
*
|
2003-01-02 |
2006-01-17 |
Femmepharma Holding Co Inc |
Preparaciones farmaceuticas para tratamientos de enfermedades y trastornos del seno.
|
|
AU2007216882B2
(en)
*
|
2003-01-02 |
2010-03-11 |
Femmepharma Holding Company, Inc. |
Pharmaceutical preparations for treatment of diseases and disorders of the breast
|
|
JP2004323454A
(ja)
*
|
2003-04-25 |
2004-11-18 |
Chisso Corp |
薬剤
|
|
JP5651279B2
(ja)
|
2003-09-03 |
2015-01-07 |
ミスコン トレイディング エス．エー． |
子宮内膜症の処置のための方法
|
|
US20060140990A1
(en)
*
|
2003-09-19 |
2006-06-29 |
Drugtech Corporation |
Composition for topical treatment of mixed vaginal infections
|
|
AU2004274000B2
(en)
*
|
2003-09-19 |
2009-07-30 |
Drugtech Corporation |
Pharmaceutical delivery system
|
|
US20050222106A1
(en)
*
|
2004-04-01 |
2005-10-06 |
Stefan Bracht |
Drospirenone-containing preparations for transdermal use
|
|
US20060040904A1
(en)
*
|
2004-08-17 |
2006-02-23 |
Ahmed Salah U |
Vaginal cream compositions, kits thereof and methods of using thereof
|
|
US7919453B2
(en)
|
2005-03-25 |
2011-04-05 |
Kimberly-Clark Worldwide, Inc. |
Dosage cap assembly for an applicator
|
|
US7993667B2
(en)
|
2005-03-25 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Methods of manufacturing a medicated tampon assembly
|
|
US7744556B2
(en)
|
2005-03-25 |
2010-06-29 |
Kimberly-Clark Worldwide, Inc. |
Delivery tube assembly for an applicator
|
|
US7527614B2
(en)
|
2005-03-25 |
2009-05-05 |
Kimberly-Clark Worldwide, Inc. |
Protective tube for a medicated tampon
|
|
US7708726B2
(en)
|
2005-04-28 |
2010-05-04 |
Kimberly-Clark Worldwide, Inc. |
Dosage form cap for an applicator
|
|
CA2605341A1
(en)
*
|
2005-05-09 |
2006-11-16 |
Drugtech Corporation |
Modified-release pharmaceutical compositions
|
|
CN101282646B
(zh)
*
|
2005-07-12 |
2013-03-27 |
Dmi生物科学公司 |
治疗疾病的方法和产品
|
|
WO2007076144A2
(en)
*
|
2005-12-27 |
2007-07-05 |
Duramed Pharmaceuticals, Inc. |
Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
|
|
CN101374501A
(zh)
*
|
2006-01-05 |
2009-02-25 |
药物技术公司 |
组合物及其使用方法
|
|
WO2007079391A2
(en)
*
|
2006-01-05 |
2007-07-12 |
Drugtech Corporation |
Drug delivery system for bioadhesion to a vulvovaginal surface
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
US20070264338A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Shah Devang T |
Base-stabilized polyorthoester formulations
|
|
US8080540B2
(en)
*
|
2006-09-19 |
2011-12-20 |
Abbott Products Gmbh |
Therapeutically active triazoles and their use
|
|
US8288367B2
(en)
|
2006-11-30 |
2012-10-16 |
Solvay Pharmaceuticals Gmbh |
Substituted estratriene derivatives as 17BETA HSD inhibitors
|
|
EP2104489A2
(en)
*
|
2006-12-26 |
2009-09-30 |
FemmePharma Holding Company, Inc. |
Topical administration of danazol
|
|
WO2008144143A1
(en)
*
|
2007-05-14 |
2008-11-27 |
Drugtech Corporation |
Endometriosis treatment
|
|
RU2327459C1
(ru)
*
|
2007-06-26 |
2008-06-27 |
Евгений Сергеевич Северин |
Лекарственное средство противомикробного действия, способ получения лекарственного препарата направленного действия, содержащего наночастицы
|
|
WO2009073782A2
(en)
*
|
2007-12-04 |
2009-06-11 |
Ams Research Corporation |
Apparatus and methods for treatment of pathologic proliferative conditions of uterine tissue
|
|
EP2359807B1
(en)
|
2008-02-04 |
2017-07-26 |
Ferring B.V. |
Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof
|
|
WO2010068827A1
(en)
*
|
2008-12-11 |
2010-06-17 |
A.P. Pharma, Inc. |
Methods for enhancing stability of polyorthoesters and their formulations
|
|
US9504274B2
(en)
*
|
2009-01-27 |
2016-11-29 |
Frito-Lay North America, Inc. |
Methods of flavor encapsulation and matrix-assisted concentration of aqueous foods and products produced therefrom
|
|
ES2523769T3
(es)
|
2009-06-22 |
2014-12-01 |
Ampio Pharmaceuticals, Inc. |
Procedimiento de tratamiento de enfermedades
|
|
SG177302A1
(en)
*
|
2009-06-22 |
2012-02-28 |
Dmi Acquisition Corp |
Methods and products for treatment of diseases
|
|
US20110003000A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Femmepharma Holding Company, Inc. |
Transvaginal Delivery of Drugs
|
|
US8597262B2
(en)
*
|
2009-07-09 |
2013-12-03 |
Ams Research Corporation |
Apparatus and methods of treatment of pathologic proliferative conditions uterine tissue
|
|
US20110033545A1
(en)
*
|
2009-08-06 |
2011-02-10 |
Absize, Inc. |
Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
|
|
EP3865502A1
(en)
*
|
2010-03-22 |
2021-08-18 |
Allergan Pharmaceuticals International Limited |
Compositions and methods for non-toxic delivery of cdb-2914
|
|
BR112014012444B1
(pt)
|
2011-11-23 |
2021-12-14 |
Therapeuticsmd, Inc |
Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
|
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
EP2934546A4
(en)
|
2012-12-19 |
2016-06-22 |
Ampio Pharmaceuticals Inc |
METHOD OF DISEASE TREATMENT
|
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
|
RU2016143081A
(ru)
|
2014-05-22 |
2018-06-26 |
Терапьютиксмд, Инк. |
Натуральные комбинированные гормонозаместительные составы и терапии
|
|
US20160008310A1
(en)
|
2014-07-11 |
2016-01-14 |
Azanta A/S |
Misoprostol dispersible tablet
|
|
DK3166597T3
(en)
|
2014-07-11 |
2025-09-01 |
Azanta Danmark As |
Misoprostol dispersibel tablet
|
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
|
US9931349B2
(en)
|
2016-04-01 |
2018-04-03 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
|
KR20200019735A
(ko)
*
|
2017-06-22 |
2020-02-24 |
비라말 리미티드 |
약물 전달을 위한 조성물 및 그의 사용 방법
|
|
BR112021007877A2
(pt)
|
2018-10-26 |
2021-08-03 |
Viramal Limited |
composição em gel mucoadesiva
|
|
EP3659583B1
(en)
|
2018-11-30 |
2023-06-07 |
Viramal Limited |
A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent
|
|
JP2023515918A
(ja)
|
2020-01-13 |
2023-04-17 |
デュレクト コーポレーション |
不純物が低減された徐放性薬物送達システム及び関連の方法
|
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
|
CA3203561A1
(en)
|
2021-01-12 |
2022-07-21 |
Adrian Neil Verity |
Sustained release drug delivery systems and related methods
|